KEGG: rms:RMA_0853
Rickettsia massiliae is a tick-borne obligate intracellular alpha-proteobacteria belonging to the spotted fever group (SFG) of Rickettsia. It causes spotted fever in humans and was first isolated in 1992. R. massiliae possesses a 1.3-Mb circular chromosome and a 15.3-kb plasmid . Phylogenetically, R. massiliae clusters with other SFG rickettsiae but contains unique genomic elements, including 14 tra genes presumably involved in pilus formation and conjugal DNA transfer, which were acquired through lateral gene transfer from a species related to Rickettsia bellii .
Molecular detection of R. massiliae is primarily accomplished through PCR targeting genes encoding citrate synthase (gltA) and outer membrane protein (ompA), followed by sequence and phylogenetic analysis . R. massiliae has been detected in multiple Rhipicephalus tick species globally, including R. turanicus, R. sanguineus s.l., and Ixodes ricinus .
Translation initiation factor IF-2 plays a critical role in bacterial protein synthesis by:
Binding to the 30S ribosomal subunit and facilitating the recruitment of the initiator tRNA (fMet-tRNA)
Promoting the formation of the 30S initiation complex
Supporting the joining of the 50S ribosomal subunit to form the 70S initiation complex
Hydrolyzing GTP during these processes, which provides energy for conformational changes
In obligate intracellular bacteria like R. massiliae, translation factors are particularly important for adaptation to the host cell environment. Research has shown that Rickettsia species can affect host translation machinery, with significant reductions observed in the abundance of translation initiation factor eIF-2B subunit delta in infected host cells . This suggests a complex interplay between bacterial and host translation systems during infection.
Studying partial recombinant IF-2 from R. massiliae is valuable for several reasons:
Diagnostic development: Recombinant rickettsial proteins are crucial for developing serological assays. Traditional IFA methods require specialized BSL-3 facilities for antigen preparation, whereas recombinant protein production only requires BSL-2 facilities .
Vaccine candidates: Surface proteins from Rickettsia are subject to intense positive natural selection, making them potential vaccine targets .
Evolutionary insights: Translation factors like IF-2 can provide phylogenetic information about the evolutionary relationships between rickettsial species .
Functional studies: Partial recombinant proteins allow for domain-specific investigations of protein function without the challenges of expressing the entire protein.
For successful expression of recombinant R. massiliae IF-2 (infB), several expression systems can be employed, each with advantages and limitations:
| Expression System | Advantages | Limitations | Optimization Strategies |
|---|---|---|---|
| E. coli (pSY5 plasmid) | High yield, low cost, rapid growth | Protein folding issues, lack of post-translational modifications | Use of fusion tags (His, GST, MBP), lowered induction temperature (16-25°C) |
| Baculovirus-insect cell | Better folding of complex proteins, suitable for eukaryotic post-translational modifications | Higher cost, longer production time | Optimize MOI, harvest time optimization |
| Cell-free systems | Avoids toxicity issues, rapid production | Lower yield, higher cost | Supplement with chaperones, optimize redox conditions |
| Mammalian cell lines | Native-like folding and modifications | Highest cost, complex protocols | Codon optimization, stable cell line development |
For R. massiliae IF-2, E. coli expression using the pSY5 plasmid has been successfully employed for other rickettsial proteins . When expressing partial IF-2, it's essential to ensure the selected region contains complete functional domains to maintain biological activity.
A robust purification and validation workflow for recombinant R. massiliae IF-2 includes:
Initial purification:
Immobilized metal affinity chromatography (IMAC) for His-tagged proteins
Glutathione affinity chromatography for GST-tagged proteins
Size exclusion chromatography for final polishing
Quality assessment:
SDS-PAGE to confirm molecular weight and purity
Western blot using anti-His/GST antibodies and/or R. massiliae-specific antisera
Mass spectrometry for protein identification and detection of post-translational modifications
Functional validation:
GTP binding and hydrolysis assays
30S ribosomal subunit binding assays
In vitro translation efficiency tests comparing wild-type and mutant versions
Structural integrity:
Circular dichroism spectroscopy
Thermal shift assays
Limited proteolysis to assess domain folding
When validating recombinant IF-2 activity, it's important to include appropriate controls, including commercially available E. coli IF-2 and other bacterial IF-2 proteins for comparative analysis.
Robust experimental design for studying R. massiliae IF-2 requires careful consideration of controls:
Negative controls:
Empty vector-transformed E. coli lysates processed identically to the recombinant protein
Irrelevant proteins of similar size and charge characteristics
Heat-denatured recombinant IF-2 protein
Positive controls:
Commercially available IF-2 from model organisms (E. coli, B. subtilis)
Previously characterized recombinant proteins using the same expression system
Native IF-2 from related Rickettsia species (if available)
Internal controls:
Include known concentrations of standard proteins for quantification
Use multiple detection methods (e.g., fluorescence and colorimetric assays)
Multi-factorial experimental design:
For example, when testing the functional activity of IF-2, a complete 2×2 factorial design might examine both temperature (25°C vs. 37°C) and pH (6.5 vs. 7.5) to identify optimal conditions and potential interaction effects between these variables.
Recombinant IF-2 can serve as a powerful tool for investigating host-pathogen interactions:
Interactome studies:
Pull-down assays with recombinant IF-2 can identify host cellular factors that interact with bacterial translation machinery
Yeast two-hybrid or mammalian two-hybrid screening to identify novel protein-protein interactions
Proximity labeling methods (BioID, APEX) in cellular models to identify proteins in close proximity to IF-2 during infection
Host response investigation:
Stimulation of host cells with recombinant IF-2 to measure inflammatory responses
Analysis of host translation factor modulation through quantitative proteomics
Examination of how R. massiliae IF-2 affects host protein synthesis rates
Comparative analysis with other Rickettsia species:
Recent studies have demonstrated that R. massiliae infection of THP-1 macrophages results in significant effects on host type I interferon responses, mRNA splicing, and protein translation machinery . This suggests that bacterial translation factors may play roles beyond protein synthesis during infection.
The evolutionary analysis of the infB gene provides insights into rickettsial evolution:
The phylogeny of Rickettsia using different evolutionary signatures shows that while extensive incongruence between individual gene trees exists, this is more plausibly attributed to systematic error than to horizontal gene transfer in core genes like infB .
Structural characterization of R. massiliae IF-2 presents several challenges:
| Challenge | Description | Potential Solutions |
|---|---|---|
| Size complexity | Full-length IF-2 is large (~100 kDa) with multiple domains | Express individual domains separately; use cryo-EM for full-length structure |
| Expression difficulties | Low solubility when expressed in heterologous systems | Test multiple fusion partners; optimize buffer conditions; use structure-guided design of soluble fragments |
| Conformational flexibility | IF-2 undergoes significant conformational changes during function | Study in complex with binding partners; use molecular dynamics simulations to model dynamics |
| Crystallization barriers | Intrinsically disordered regions can hinder crystallization | Use limited proteolysis to identify stable domains; employ surface entropy reduction mutations |
Recent advances that can overcome these challenges include:
Hybrid structural approaches:
Combining X-ray crystallography of domains with cryo-EM of larger assemblies
Integrating small-angle X-ray scattering (SAXS) with NMR spectroscopy
Using AlphaFold2 or similar AI tools to predict structures and guide experimental design
Dynamic structural analysis:
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map conformational changes
Single-molecule FRET to observe real-time conformational dynamics
Time-resolved cryo-EM to capture different functional states
Understanding the structure of R. massiliae IF-2 would provide valuable insights into both bacterial translation mechanisms and potential targets for therapeutic intervention.
Recombinant IF-2 offers promising applications for R. massiliae diagnostics:
Serological assay development:
ELISA-based detection using recombinant IF-2 as a capture antigen
Multiplex bead-based assays incorporating multiple rickettsial recombinant proteins
Lateral flow immunoassays for point-of-care testing
Advantages over traditional methods:
IFA for rickettsial diseases requires personnel expertise, specialized facilities, and has subjective results interpretation
Recombinant protein ELISA only requires BSL-2 facilities and is better suited for high-throughput work in low-income settings
Recombinant proteins offer more standardized antigen preparation
Performance considerations:
When developing recombinant protein diagnostics, sensitivity and specificity vary significantly based on the protein used
In one comparative study of rickettsial recombinant protein diagnostics, OmpB-typhi demonstrated sensitivity of 72.2% and specificity of 73.4%, while OmpA-L showed poorer performance (61.5% sensitivity, 61.1% specificity)
IF-2 diagnostics would need validation against these established recombinant protein targets
For optimal diagnostic performance, combining multiple recombinant antigens (including IF-2) may provide improved sensitivity and specificity compared to single-antigen approaches.
Translation initiation factor IF-2 represents a potential therapeutic target due to several characteristics:
Target validation considerations:
Essential role in bacterial protein synthesis
Structural and functional differences from mammalian counterparts
Accessibility to small molecule inhibitors
Therapeutic approaches:
Small molecule inhibitors of GTPase activity
Peptide mimetics disrupting IF-2 interactions with ribosomal components
Antisense oligonucleotides targeting infB mRNA
Challenges in development:
Delivery of therapeutics to intracellular bacteria
Potential for cross-reactivity with human translation factors
Need for penetration of both bacterial and host cell membranes
Combination therapy potential:
IF-2 inhibitors could be synergistic with current antibiotic treatments
Targeting bacterial translation could reduce virulence factor production
Current antibiotic treatments for R. massiliae infections typically involve doxycycline, but the development of translation-targeting therapeutics could provide alternatives for resistant cases or patients with contraindications to standard treatments.
Several cutting-edge technologies show promise for advancing R. massiliae IF-2 research:
CRISPR-based technologies:
CRISPR interference (CRISPRi) to modulate host factors that interact with bacterial IF-2
CRISPRa to upregulate host defensive factors against rickettsial infection
Base editing to introduce specific mutations in host factors that interact with IF-2
Advanced imaging approaches:
Super-resolution microscopy to visualize IF-2 localization during infection
Expansion microscopy to enhance visualization of host-pathogen interfaces
Live-cell imaging with tagged IF-2 to track dynamics during infection
Multi-omics integration:
Combining transcriptomics, proteomics, and metabolomics to understand the impact of IF-2 on host cellular processes
Single-cell approaches to characterize heterogeneity in host responses
Spatial transcriptomics to map infection progression in tissues
Microfluidic systems:
Organ-on-chip models to study rickettsial infections in complex tissue environments
Droplet-based systems for high-throughput screening of translation inhibitors
Microfluidic co-culture systems to model vector-host-pathogen interactions
The integration of these technologies with traditional biochemical approaches will provide unprecedented insights into rickettsial translation factors and their roles in pathogenesis.
Comparative analysis of IF-2 across different Rickettsia species can reveal insights into virulence mechanisms:
Correlation with disease severity:
Compare IF-2 sequence and activity between highly pathogenic species (R. rickettsii) and mildly pathogenic ones (R. massiliae)
Identify specific domains or residues that correlate with clinical outcomes
Host adaptation signatures:
Analyze IF-2 from species with different host ranges (human-specific vs. broader host range)
Identify potential host-specific adaptations in IF-2 function
Vector-specific adaptations:
Compare IF-2 from Rickettsia species transmitted by different tick vectors
Investigate whether IF-2 variations contribute to vector competence
Experimental approaches:
Domain-swapping experiments between IF-2 from different species
Site-directed mutagenesis of specific residues identified in comparative analyses
Cross-species complementation studies to assess functional conservation
Studies of spotted fever group Rickettsia have demonstrated that they trigger species-specific alterations in host cell responses . Understanding the role of IF-2 in these differential responses could provide valuable insights into pathogenicity mechanisms.